COVID-19 Third Dose Authorized for Immunocompromised
FDA authorizes the third dose of mRNA COVID-19 vaccine to those who are immunocompromised.
According to the CDC, as of August 12, the FDA has modified the Emergency Use Authorizations (EAUs) for Pfizer-BioNTech and Moderna COVID-19 vaccines for the administration of an additional third dose of an mRNA COVID-19 vaccine.